Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China flag China · Delayed Price · Currency is CNY
349.79
+1.79 (0.51%)
At close: Sep 12, 2025

SHA:688506 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
140,26676,88456,100---
Upgrade
Market Cap Growth
63.24%37.05%----
Upgrade
Enterprise Value
137,87473,45856,019---
Upgrade
Last Close Price
349.79191.73139.90---
Upgrade
PE Ratio
-20.74----
Upgrade
Forward PE
-71.91----
Upgrade
PS Ratio
317.9313.2099.85---
Upgrade
PB Ratio
50.1119.79369.39---
Upgrade
P/TBV Ratio
50.6519.92452.87---
Upgrade
P/FCF Ratio
-19.34----
Upgrade
P/OCF Ratio
-18.94----
Upgrade
EV/Sales Ratio
-12.6299.70---
Upgrade
EV/EBITDA Ratio
-19.57----
Upgrade
EV/EBIT Ratio
-19.93----
Upgrade
EV/FCF Ratio
-60.7118.48----
Upgrade
Debt / Equity Ratio
1.110.534.530.590.870.33
Upgrade
Debt / EBITDA Ratio
-0.55---5.68
Upgrade
Debt / FCF Ratio
-0.52---2.38
Upgrade
Asset Turnover
0.061.360.330.480.800.95
Upgrade
Inventory Turnover
1.551.872.002.592.752.82
Upgrade
Quick Ratio
3.292.990.521.730.620.89
Upgrade
Current Ratio
3.663.190.741.940.901.07
Upgrade
Return on Equity (ROE)
-54.45%183.64%-143.77%-44.62%-25.51%8.62%
Upgrade
Return on Assets (ROA)
-19.57%53.82%-28.74%-14.01%-10.00%-1.34%
Upgrade
Return on Capital (ROIC)
-23.62%67.82%-42.30%-19.63%-16.33%-2.33%
Upgrade
Return on Capital Employed (ROCE)
-71.50%----
Upgrade
Earnings Yield
-1.48%4.82%-1.39%---
Upgrade
FCF Yield
-1.62%5.17%-1.24%---
Upgrade
Payout Ratio
-1.03%---26.28%
Upgrade
Buyback Yield / Dilution
-0.05%-0.14%-10.56%-1.38%-3.64%10.86%
Upgrade
Total Shareholder Return
--0.14%-10.56%-1.38%-3.64%10.86%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.